Back
Novo Nordisk A/S Stock Price Chart
Sponsored
NVO
Sponsored
Biden's Oil War: The Administration Is All-In on Green Energy.
Download Free Report
Buy
60
NVO
Novo Nordisk A/S
Last Price:
129.57
Seasonality Move:
4.81%
7 Day Trial
ALL ACCESS PASS
$
7
Billionaire Investors Join Forces to Fund Next Generation
Learn More- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing slight buying pressure.
Novo Nordisk A/S Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.97 | Sell |
20-day SMA: | 129.84 | Sell |
50-day SMA: | 121.43 | Buy |
200-day SMA: | 100.14 | Buy |
8-day EMA: | 129.64 | Sell |
20-day EMA: | 128.72 | Sell |
50-day EMA: | 122.41 | Buy |
200-day EMA: | 103.15 | Buy |
Novo Nordisk A/S Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.18 | Buy |
Relative Strength Index (14 RSI): | 51.65 | Buy |
Chaikin Money Flow: | 561664 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (123.94 - 133.02) | Sell |
Bollinger Bands (100): | (99.63 - 123.53) | Buy |
Novo Nordisk A/S Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Novo Nordisk A/S Stock
Is Novo Nordisk A/S Stock a Buy?
- Novo Nordisk A/S share price is 128.05 while NVO 8-day simple moving average is 129.97, which is a Sell signal.
- The stock price of NVO is 128.05 while Novo Nordisk A/S 20-day SMA is 129.84, which makes it a Sell.
- Novo Nordisk A/S 50-day simple moving average is 121.43 while NVO share price is 128.05, making it a Buy technically.
- NVO stock price is 128.05 and Novo Nordisk A/S 200-day simple moving average is 100.14, creating a Buy signal.
NVO Technical Analysis vs Fundamental Analysis
Buy
60
Novo Nordisk A/S (NVO)
is a Buy
Is Novo Nordisk A/S a Buy or a Sell?
-
Novo Nordisk A/S stock is rated a Buy
The current Novo Nordisk A/S [NVO] share price is $128.05. The Score for NVO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Novo Nordisk A/S Stock Info
Market Cap:
571.36B
Price in USD:
128.05
Share Volume:
3.93M
Novo Nordisk A/S 52-Week Range
52-Week High:
138.28
52-Week Low:
75.56
Buy
60
Novo Nordisk A/S (NVO)
is a Buy
Novo Nordisk A/S Share Price Forecast
-
What is the Novo Nordisk A/S stock price today?
The Novo Nordisk A/S stock price is 128.05 USD today. -
Will NVO stock go up or go down?
Novo Nordisk A/S> share price is forecast to RISE/FALL based on technical indicators -
Is Novo Nordisk A/S overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk A/S is not overvalued.
Is Novo Nordisk A/S Stock a Buy?
- Novo Nordisk A/S share price is 128.05 while NVO 8-day exponential moving average is 129.64, which is a Sell signal.
- The stock price of NVO is 128.05 while Novo Nordisk A/S 20-day EMA is 128.72, which makes it a Sell.
- Novo Nordisk A/S 50-day exponential moving average is 122.41 while NVO share price is 128.05, making it a Buy technically.
- NVO stock price is 128.05 and Novo Nordisk A/S 200-day simple moving average is 103.15, creating a Buy signal.
Fundamental Analysis of Novo Nordisk A/S
Is Novo Nordisk A/S a good investment?
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.72 per share.
Technical Analysis of Novo Nordisk A/S
Should I short Novo Nordisk A/S stock?
- NVO Moving Average Covergence Divergence (MACD) indicator is 2.18, suggesting Novo Nordisk A/S is a Buy
- Novo Nordisk A/S Relative Strength Index (RSI) is 51.65, which suggest Novo Nordisk A/S is overbought
- The Bollinger Bands (25) for Novo Nordisk A/S is (123.94 - 133.02), which suggest Novo Nordisk A/S is a Buy
- The Bollinger Bands (100) for Novo Nordisk A/S is (99.63 - 123.53), which suggest Novo Nordisk A/S is a Buy
* Novo Nordisk A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.